Who can apply?

            All undergraduate students of Pharmacy, Chemistry, Nursing and Health and Allied Sciences who have thesis proposals on Natural products may apply. The proposed study must use plants indigenous in the region. The project must be completed a year after receiving the grant.

Selection Criteria

  1. Technical merit

In order to guide the RHRDC Technical Review committees, the Foundation for the Advancement of Clinical Epidemiology (FACE) Inc. leads a Consultative Meeting for the development of a Technical Review Manual of Operations on January 11-12, 2018 at the Summit Hotel, General Maxilom Avenue Extension B. Benedicto Street, Cebu City. This is to primarily gather more comments and insights from the RHRDC representatives after the manual’s revision in late 2017.

In attendance to the said huddle are the Consortium Chairs, RMC Chairs, and Regional Project Staffs who gave additional inputs on the various components of the manual.

The said manual is envisioned to guide the RHRDC Technical Review Committees and its members in an efficient and effective way with regards to the performance of their functions in the technical review of proposal submissions to their committee. This manual will also help research investigators on the requirements and flow of the processes that their grant submissions will undergo and the steps they have to take as the review process is ongoing. This will hopefully simplify the organization, processes, and documentation of the TRB operations while maintaining high standards, transparency, and accountability.

The 2-day plenary workshop highlighted the different responsibilities of the Regional Management Committee, Technical Review Board, and the Secretariat. It also emphasized the flow of review process and agreed timelines.

Dr. Noel Juban, the lead coordinator, said that once finalized, the manual will be launched during the Philippine Council for Health Research and Development (PCHRD) 36th Anniversary in March 2018.

On December 19, 2017, the Cordillera Regional Health Research and Development Consortium (CRHRDC) conducted its Grand Awarding Ceremony 2017 at the Audio-Visual Room, College of Social Sciences (CSS-AVR), University of the Philippines Baguio. This annual event aims to give due recognition to the nominees and awardees from the member institutions of the Consortium for their exceptional contributions to the health research community. 


DOH-CAR on Dengue Vaccine Dengvaxia
December 1, 2017

Dengvaxia, the first WHO-approved dengue vaccine in the world is manufactured by Sanofi Pasteur, a French pharmaceutical company. After extensive clinical trials, it was shown to be protective against the four serotypes of the dengue virus: Den-1, Den-2, Den-3, and Den-4. It was also found to be capable of decreasing the occurrence of severe dengue by about 83% and hospitalization by about 90%.

In 2016, the DOH immunized an estimated total of 700,000 public school students aged nine years old through the Dengue Immunization Program. This was implemented in the NCR, Region IV-A, and Region III – the regions having the highest incidence of dengue through the years. On December 1, the program has been put on hold by the DOH.

Despite that the Dengue Immunization Program was not implemented in the Cordillera Region, the vaccine was made available to the private sector by Sanofi Pasteur. This means that some citizens, including children, may have availed of the vaccine through private health practitioners.

On November 29, 2017, Sanofi Pasteur revealed a new analysis stating that “Dengvaxia provides persistent protective benefit against dengue fever in those who had prior infection. For those not previously infected by dengue virus, however, the analysis found that in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection.”

Based on the entire analysis, those who are immunized with the vaccine, without previous dengue infection, are protected from dengue infection for at least 30 months. However, severe dengue could or may occur if they are bitten by an infected Aedes mosquito and no immediate consultation has been done. For this reason, everyone who has no dengue and who is vaccinated should be monitored for any signs of dengue and should seek early consultation.

The DOH-CAR is appealing to all medical practitioners in the Cordillera who provided Dengvaxia to their patients to conduct active surveillance and monitor and advise their patients to seek immediate consultation when having signs and symptoms.

To all individuals who received the vaccine, the best course of action is to avoid getting the disease through prevention. Their surroundings must be kept free from mosquito breeding sites. They must also exercise self-protection measures such as wearing protective clothing and using FDA-approved mosquito repellants.

Tokens awarded to the resource speaker as parting gifts by the event organizers. (L-R) Ms. Carmen Bolinto (representing the Philippine Nurses Association - Baguio City Chapter); Dr. Erlinda Palaganas (Chair, CRHRDC Capability Building Committee); Ms. Teresa Bastan (representing the Saint Louis University - School of Nursing Faculty); Dr. Dalmacio Dennis Flores III, PhD, ACRN (Resource Speaker from the University of Pennsylvania); and Dr. Raymundo Rovillos (Chair, CRHRDC and Chancellor, University of the Philippines Baguio)


The Cordillera Regional Health Research and Development Consortium (CRHRDC), through its Capability Building Committee, in collaboration with the Philippine Nurses Association - Baguio City Chapter and the Saint Louis University - School of Nursing, initiated the colloquium on Conducting Qualitative Metasynthesis: Insights from a New Investigator with the dynamic and very humble resource speaker, Mr. Dalmacio Dennis Flores III, PhD, ACRN (University of Pennsylvania). This was conducted on 9 December 2017 at the AVR, College of Social Sciences, University of the Philippines Baguio.

Qualitative metasynthesis is not a new approach in research. However, a few researchers are adept in utilizing such approach along with meta-analysis. This process requires rigorous qualitative methods to synthesize existing qualitative studies to construct greater meaning through an interpretative process. The purpose of the seminar is to describe qualitative metasynthesis as an innovative research approach as it can offer a promising practice in many fields. The seminar also aimed to further explore how qualitative metasynthesis can be a practical and effective approach of inquiry as they continue to broaden their understanding about numerous phenomena (Erwin, Brotherson Summers, 2011).



Please rate your experience using this page

How can we make this page better for you?
Maximum of 250 characters only.
Please select Affiliation:


Copyright © Cordillera Regional Health Research and Development Consortium. All Rights Reserved.